StockClub

ERGO

ERGOEntia Biosciences, Inc.$ --
Entia Biosciences, Inc.

Entia Biosciences, Inc.

ERGO

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2016FY2016 Q4
Revenue
0M USD
YoY -32.8%
Operating Income
-0M USD
YoY -96.4%
Net Income
-0M USD
YoY -51.5%
EPS
-0.02$
YoY -57.5%

Revenue

$265,466
FY2015 Q1$102,329
$102,329
Q1
FY2015 Q2$210,465
$210,465
Q2
FY2015 Q3$278,513
$278,513
Q3
FY2015 Q4$346,910
$346,910
Q4
FY2016 Q1$79,200
$79,200
Q1
FY2016 Q2$177,625
$177,625
Q2
FY2016 Q3$219,480
$219,480
Q3
FY2016 Q4$265,466
$265,466
Q4
Actual
$-81,444 (-23.5%)

Net Income

$-1.5M
FY2015 Q1$-520,509
$-520,509
Q1
FY2015 Q2$-1.6M
$-1.6M
Q2
FY2015 Q3$-2M
$-2M
Q3
FY2015 Q4$-2.3M
$-2.3M
Q4
FY2016 Q1$-279,986
$-279,986
Q1
FY2016 Q2$-699,505
$-699,505
Q2
FY2016 Q3$-1M
$-1M
Q3
FY2016 Q4$-1.5M
$-1.5M
Q4
Actual
+$794,127 (+35.0%)

Surprise History

Actual RevenueAnalyst Estimate
FY2011
Actual:$403,338
FY2011
$403,338
FY2012
Actual:$369,273
FY2012
$369,273
FY2013
Actual:$314,746
FY2013
$314,746
FY2014
Actual:$656,342
FY2014
$656,342
FY2015
Actual:$346,910
FY2015
$346,910
FY2016
Actual:$265,466
FY2016
$265,466

Analyst Estimates

No forecast data